Major congenital malformations after first-trimester exposure to ACE inhibitors. - Wikidata - wikimedia - TriplyDB

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

http://www.wikidata.org/entity/Q34535854

about

Teratogenic mechanisms of medical drugs Standards of medical care in diabetes--2012 Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby Pre-conception counselling for key cardiovascular conditions in Africa: optimising pregnancy outcomes Management of Type 1 Diabetes in Pregnancy Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks The treatment of hypertension during pregnancy: when should blood pressure medications be started?Drug treatment of hypertension in pregnancy A Comprehensive Review of Hypertension in Pregnancy 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain The effects of periconceptional risk factor exposure and micronutrient supplementation on birth defects in Shaanxi Province in Western China EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations Standards of medical care in diabetes--2013 The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.Women, kidney disease, and pregnancy Standards of medical care in diabetes--2010.Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study.Role of the kidney in the prenatal and early postnatal programming of hypertension Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits.Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Acute coronary syndrome in pregnancy.Pregnancy in a patient with cancer and heart failure: challenges and complexities.Nephropathy in youth and young adults with type 2 diabetes Pre-eclampsia, eclampsia, and hypertension Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data.Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.Vascular Complications of Systemic Sclerosis during Pregnancy.Genetic basis of congenital cardiovascular malformations Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.Medical databases in studies of drug teratogenicity: methodological issues Hypertension in women of reproductive age in the United States: NHANES 1999-2008.Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population.

P2860

Q22337136-434384FD-E96E-4D5F-9D49-05D25D7E84AD Q24632533-AC73F4C8-14D5-4DF1-BF89-50C267863785 Q24644292-2DE09312-8D9B-4539-92BF-6468F678A10E Q24658205-02E96077-FE29-48A5-810F-690A8F9E9044 Q26741002-8A669E75-1619-41C2-905A-DBF7876D740F Q26746827-121AFF97-3112-47B8-ADD6-B023C017CF85 Q26747535-7CF47592-D05B-46AF-9224-F0B87BF64BCF Q26991704-92707D1A-7EA1-4F50-9B25-D1147CA4156D Q26994764-07D46DBE-CC8C-447A-A43D-301FC4BC8E2E Q27014718-8C3D9BC6-B72E-4B2E-8DA4-5D69AE5BABA7 Q27495953-43F54262-C6EB-4A06-8FF5-FD686A2C6D9A Q28087002-FD08AEAF-8CD0-4E6D-9D46-CB4E41AD2D5B Q28473818-F5349BD7-257A-4EA5-BDEE-4EE466C9D536 Q28484666-17CAE02B-105A-481D-980C-D4A1B79B7AFF Q28817912-80D95F27-4ABE-43AE-AB2E-D624CEC34C81 Q29620309-8388EF51-826A-4276-8380-01F11057BCEF Q30973898-3024DD07-1AFE-490A-A188-5E86B5A04526 Q31131743-04853063-1AB1-4B31-8870-DF18EDE96486 Q31145022-D4196488-0384-435E-9D2D-198D8E1B4C9C Q33410001-9742FC18-B287-400F-BFEA-AD13A3732FF3 Q33554238-D7A84049-2E57-4600-BED0-0A27AC5D6C96 Q33556930-F6CD75C2-AD6C-4578-95F2-630326A832CE Q33655692-6E8BD169-2535-4D9D-9898-48D08178421E Q33811985-9805D33D-7ED9-40B0-8E4E-1B779FA4F5F1 Q33829396-4BD2808F-D46A-4914-BB4C-ED9566E9ADA4 Q33842357-4D7C66F7-34C3-4FB7-AA8C-090A006B0B3E Q33844319-CACB8A30-4AEB-45A3-93F7-E77712B8B231 Q33860225-2C782BB5-A351-4263-B669-DBDAB6CB5DEF Q33885550-1A0AB865-E23F-4C6D-A29B-024450316EF7 Q33903763-F3840BE6-709A-4368-8117-267F25C5F842 Q33947390-C8F5EB3F-AD0B-48C3-8404-8234D766CD06 Q33992849-D92D4989-20C8-41E9-917B-73E5DC788B68 Q34058190-EA34B7C9-BC41-45BD-ABEA-00CE78E62A63 Q34095380-C24A42C7-D21E-4F22-A1FE-13B8BA822192 Q34097385-A51446EA-ECE0-4D2E-B879-16650D0FBDAB Q34125381-5BE69C9D-5729-458D-9AE6-9F029278C4F9 Q34135348-6CDEC97D-AC92-44B4-B939-3E274CDEAFCF Q34144164-49B9D531-6DBC-4B92-A2FA-903E4BCA4499 Q34257254-36AE46FB-BD2A-44C6-BFF0-406D9D45170E Q34298992-681A0E0A-F6EE-426F-8521-7D74CFCFF7D7

P2860

Major congenital malformations after first-trimester exposure to ACE inhibitors.

http://www.wikidata.org/entity/Q34535854

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@ast

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@en

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@nl

type

label

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@ast

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@en

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@nl

prefLabel

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@ast

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@en

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@nl

P1433

Q34535854-E5B6A765-0944-4B79-989E-324CE7347DB3

P1476

Q34535854-31DDAA06-B6BE-43F6-813A-3A3783705AF3

P2093

Q34535854-0FC80EF6-3B66-4CE6-A84C-2CD465F5460E

Q34535854-465A201A-FB20-4BB6-8B5B-E89843F1627C

Q34535854-4E0FF1DC-40A4-4217-9D94-5A3C5AAD4985

Q34535854-5C3180E7-A7E7-46F7-85A8-87E03C6D6194

Q34535854-84E4EEB0-BE93-49FA-BB9A-6C8649726CA0

Q34535854-94F57842-FF6A-4D93-8228-F397B3032878

Q34535854-9CE26216-82F4-42EF-AF2F-69E4CF874347

Q34535854-ADE2D84F-104F-49BB-BAF7-D1EE573EEBB4

P304

Q34535854-2B454059-B57F-45CC-AA4A-B75C52610F34

P31

Q34535854-31D7DB51-6786-4BAF-B109-5C64AD2A3AFC

P356

Q34535854-A7D24470-70F9-45BD-8B05-3E9A6E984775

P407

Q34535854-885C7341-BD95-416F-9DB5-C1C1DC74F11C

P433

Q34535854-62EB4478-E357-4961-BB77-E4E0C7621602

P478

Q34535854-19A8C1E0-A292-4E0A-A564-F244ABBE4811

P577

Q34535854-81811184-414E-468F-8E37-298C3C6FBD93

P5875

Q34535854-21B70D3B-DA74-4A04-87FD-009D0AD4ABAF

P698

Q34535854-AE9F3A48-7F13-4A40-A2D3-31A2E83EA3CB

P921

Q34535854-F9DF47AE-0CB1-4785-A976-B94E8DB6DAC6

P356

P1433

The New England Journal of Medicine

P1476

Major congenital malformations after first-trimester exposure to ACE inhibitors.

@en

P2093

Judith A Dudley

http://www.w3.org/2001/XMLSchema#string

Kathi Hall

http://www.w3.org/2001/XMLSchema#string

Patricia S Gideon

http://www.w3.org/2001/XMLSchema#string

Patrick G Arbogast

http://www.w3.org/2001/XMLSchema#string

Shannon Dyer

http://www.w3.org/2001/XMLSchema#string

Sonia Hernandez-Diaz

http://www.w3.org/2001/XMLSchema#string

Wayne A Ray

http://www.w3.org/2001/XMLSchema#string

William O Cooper

http://www.w3.org/2001/XMLSchema#string

P304

2443-2451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA055202

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

354

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7023573

http://www.w3.org/2001/XMLSchema#string

P698

16760444

http://www.w3.org/2001/XMLSchema#string

P921